NICE TA717 - for treating relapsed follicular lymphoma after 2 or
more systemic therapies. (Terminated appraisal). (Decision date - August 2021).
NICE TA811 - for treating relapsed or refractory chronic
lymphocytic leukaemia after 2 or more treatments. (Terminated appraisal). (Decision date - August 2022).
Do Not Prescribe (DNP) Drug Classifications
6: Have NICE guidance that recommends they should not be used
